Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated Interferon Lambda-1a with Ribavirin and Daclatasvir in HCV/HIV Co-infection
NCT01866930Phase 3Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2013
- Primary completion
- Aug 2015
- Modality
- Cytokines & Interferons
- Countries
- 12
01
Overview
A Phase 3 trial of peginterferon lambda-1a in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started Jul 2013; status: terminated.
02
Drugs
peginterferon lambda-1a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01866930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01866930.